ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,128.34
1.27%
Dow Jones
38,688.01
1.21%
US Dollar vs MXN
16.9677
-0.03%
Brent Oil
82.775
-1.02%
Bitcoin
61,846.81
4.61%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Predictive Oncology Inc (POAI)

  7. Predictive Oncology Inc (POAI) Noticias

POAI

Predictive Oncology (POAI)

Predictive Oncology Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:POAI
FechaHoraFuenteTítuloSímboloCompañía
08/02/202416:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:POAIPredictive Oncology Inc
07/12/202307:54Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:POAIPredictive Oncology Inc
05/12/202315:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:POAIPredictive Oncology Inc
13/11/202316:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:POAIPredictive Oncology Inc
04/10/202316:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:POAIPredictive Oncology Inc
15/05/202316:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:POAIPredictive Oncology Inc
12/05/202317:42Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:POAIPredictive Oncology Inc
02/05/202316:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:POAIPredictive Oncology Inc
18/04/202305:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:POAIPredictive Oncology Inc
17/04/202317:00GlobeNewswire Inc.Predictive Oncology Adjourns Special Meeting of StockholdersNASDAQ:POAIPredictive Oncology Inc
05/04/202312:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:POAIPredictive Oncology Inc
29/03/202316:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:POAIPredictive Oncology Inc
17/03/202316:11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:POAIPredictive Oncology Inc
16/03/202316:15GlobeNewswire Inc.Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common StockNASDAQ:POAIPredictive Oncology Inc
16/03/202316:11Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:POAIPredictive Oncology Inc
09/03/202307:30GlobeNewswire Inc.Predictive Oncology Issues Letter to ShareholdersNASDAQ:POAIPredictive Oncology Inc
28/02/202316:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:POAIPredictive Oncology Inc
23/02/202307:30GlobeNewswire Inc.Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligenceNASDAQ:POAIPredictive Oncology Inc
21/02/202307:30GlobeNewswire Inc.Predictive Oncology launches ACE program to partner with academic and research institutions to advance their drug discovery initiativesNASDAQ:POAIPredictive Oncology Inc
03/02/202307:31GlobeNewswire Inc.Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business OfficerNASDAQ:POAIPredictive Oncology Inc
12/01/202307:30GlobeNewswire Inc.Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
13/12/202207:30GlobeNewswire Inc.Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
05/12/202207:30GlobeNewswire Inc.Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of DirectorsNASDAQ:POAIPredictive Oncology Inc
10/11/202216:15GlobeNewswire Inc.Predictive Oncology Reports Third Quarter Financial ResultsNASDAQ:POAIPredictive Oncology Inc
25/10/202207:30GlobeNewswire Inc.David S. Smith appointed to the Board of Directors of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
20/10/202207:30GlobeNewswire Inc.Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare to Lead Company GrowthNASDAQ:POAIPredictive Oncology Inc
14/10/202205:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:POAIPredictive Oncology Inc
13/10/202216:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:POAIPredictive Oncology Inc
30/09/202216:07Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:POAIPredictive Oncology Inc
19/09/202207:30GlobeNewswire Inc.Predictive Oncology Strengthens Offerings with GMP Lab and Addition of Leading Expert in Formulation DevelopmentNASDAQ:POAIPredictive Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:POAI

Su Consulta Reciente

NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
BAC
Bank of America
NASDAQ
TSLA
Tesla
USOTC
ADDYY
Adidas (QX)
CCOM
OILBRENT
Brent Oil
CCOM
US500
US 500
NYSE
MCD
McDonalds
FX
USDMXN
US Dollar vs MXN
COIN
ETHUSD
Ethereum
USOTC
RHHBY
Roche (QX)
NASDAQ
AMZN
Amazon.com
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados